Diagnocine's human IL17A ELISA kit is an in vitro enzyme-linked immunosorbent assay for the quantitative determination of IL17A concentrations in serum, plasma, and tissue homogenates. This assay exclusively recognizes human IL17A. The quantitative sandwich ELISA technique of this kit is based on IL17A antibody-IL17A antigen interactions and an HRP colorimetric detection system to detect the levels of IL17A in samples. The intensity of the color is positively proportional to the amount of bound IL17A in the initial step.

IL-17, also known as IL17A, is a key pri-inflammatory cytokine that links T cell activation to neutrophil mobilization and activation. It not only protects the host against extracellular pathogens but also helps to clear intracellular pathogens. IL-17 binding to IL-17RA and IL-17RC activates the ACT1-mediated NF-κB pathway, inducing the production of many inflammatory genes, including TNFα, IL-6, and IL-1. Dysregulated IL-17 production or signaling often leads to unresolved inflammation, resulting in the autoimmune response and tissue destruction. Uncontrolled IL-17 activity is related to different immunopathological conditions, autoimmune disorders, and cancer progression. IL-17 has been shown to promote the formation, growth, and metastasis of various tumors.

CTLA 8 ELISA Kit; CTLA-8 ELISA Kit; CTLA8 ELISA Kit; cytotoxic T lymphocyte associated antigen 8 ELISA Kit; Cytotoxic T lymphocyte associated protein 8 ELISA Kit; Cytotoxic T lymphocyte associated serine esterase 8 ELISA Kit; Cytotoxic T-lymphocyte-associated antigen 8 ELISA Kit; IL 17 ELISA Kit; IL 17A ELISA Kit; IL-17 ELISA Kit; IL-17A ELISA Kit; IL17 ELISA Kit; IL17_HUMAN ELISA Kit; Il17a ELISA Kit; Interleukin 17 (cytotoxic T lymphocyte associated serine esterase 8) ELISA Kit; interleukin 17A ELISA Kit; Interleukin-17A ELISA Kit; interleukin17 ELISA Kit; Interleukin17A ELISA Kit; OTTHUMP00000016597 ELISA Kit; OTTMUSP00000046003 ELISA Kit

Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation. Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites. In airway epithelium, mediates neutrophil chemotaxis via induction of CXCL1 and CXCL5 chemokines. In secondary lymphoid organs, contributes to germinal center formation by regulating the chemotactic response of B cells to CXCL12 and CXCL13, enhancing retention of B cells within the germinal centers, B cell somatic hypermutation rate and selection toward plasma cells. Effector cytokine of a subset of gamma-delta T cells that functions as part of an inflammatory circuit downstream IL1B, TLR2 and IL23A-IL12B to promote neutrophil recruitment for efficient bacterial clearance. Effector cytokine of innate immune cells including invariant natural killer cell (iNKT) and group 3 innate lymphoid cells that mediate initial neutrophilic inflammation. Involved in the maintenance of the integrity of epithelial barriers during homeostasis and pathogen infection. Upon acute injury, has a direct role in epithelial barrier formation by regulating OCLN localization and tight junction biogenesis. As part of the mucosal immune response induced by commensal bacteria, enhances host's ability to resist pathogenic bacterial and fungal infections by promoting neutrophil recruitment and antimicrobial peptides release. In synergy with IL17F, mediates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers. Involved in antiviral host defense through various mechanisms. Enhances immunity against West Nile virus by promoting T cell cytotoxicity. May play a beneficial role in influenza A virus (H5N1) infection by enhancing B cell recruitment and immune response in the lung. Contributes to influenza A virus (H1N1) clearance by driving the differentiation of B-1a B cells, providing for production of virus-specific IgM antibodies at first line of host defense.